Clinical Trial Update: An Asian Study to Assess the Properties and Profile of Ticagrelor in Patients With Stable Coronary Artery Disease [Phase 2]

View source ↗

Summary

This Clinical Trials update reports Phase 2 results evaluating ticagrelor in patients with stable coronary artery disease to assess its properties and profile. …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stable Coronary Artery Disease

Drugs mentioned

• TICAGRELOR (ticagrelor)

Snippet

Sponsor: AstraZeneca | Conditions: Stable Coronary Artery Disease | Phase 2 | Status: COMPLETED | Results posted: 2012-04-09